Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or...

GSK Korea, first approval of multiple myeloma treatment ‘Blenrep’ ADC

Enhertu granted breakthrough therapy designation in the US as post-neoadjuvant therapy for patients with HER2-positive...

PeptiDream announces FDA clearance of IND applications for Phase 1 clinical trials of 225Ac-PD-32766 and...

Simcere Zaiming builds exclusive partnership with Ipsen for Simcere Zaiming’s innovative antibody drug conjugate

Tongyi Pharmaceuticals announced that it has entered into an exclusive licensing agreement with MultiValent Biotherapies...